References
- Engel AG. The myasthenic syndromes. New York: Oxford University Press, 1999.
- Conti-Fine BM, Kaminski HJ. Autoimmune neuromuscular transmission disorders: myasthenia gravis and Lambert-Eaton myasthenic syndrome. Continuum.2001;7:56–93.
- Grob D, Arsura EL, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann NY Acad Sci. 1987; 505:472–499.
- Kaminski HJ, Maas E, Spiegel P, Ruff RL. Why are eye muscles frequently involved by myasthenia gravis? Neurology. 1990;40:1663–1669.
- Boonyapisit K, Kaminski HJ, Ruff RL. The molecular basis of neuromuscular transmission disorders. Am J Med. 1999;106:97–113.
- Engel A. The myasthenic syndromes.Oxford: Oxford University Press; 1999.
- Ruff RL, Whittlesey D. Na + currents near and away from endplates on human fast and slow twitch muscle fibers. Muscle Nerve. 1993;16:922–929.
- Ruff RL, Whittlesey D. Na + current densities and voltage dependence in human intercostal muscle fibres. J Physiol (London). 1992;458:85–97.
- Wood S, Slater C. The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles. J Physiol. 1997;500: 165–176.
- Kaminski HJ, Kusner LL, Block CH. Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Invest Ophthalmol Vis Sci. 1996;37:345–351.
- Kaminski HJ, Kusner LL, Nash KY, Ruff RL. The y-subunit of the acetylcholine receptor is not expressed in the levator palpebrae superioris. Neurology. 1995;45:516–518.
- Horton RM, Manfredi AA, Conti-Tronconi BM. The 'embryonic' gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle. Neurology. 1993;43:983–986.
- Missias AC, Chu GC, Klocke BJ, Sanes JR, Merlie JP. Regulation of the acetylcholine receptor gamma subunit gene in developing skeletal muscle: analysis with subunit-specific antibodies, transgenic mice, and cultured cells. Dev Biol. 1996;179: 223.
- Ruff RL, Lennon V. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis. Ann Neurol. 1998;43:370–379.
- Blaes F, Beeson D, Plested P, Lang B, Vincent A. IgG from `seronegative' myasthenia gravis patients binds to a muscle cell line, TE671, but not to a human acetylcholine receptor. Ann Neurol. 2000;47: 504–510.
- Hoch W, McConville J, Helms S, Newsom-Davis J, Me1ms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.Nat Med. 200I;7(3):365–368.
- Spencer RF, Porter JD. Structural organization of the extraocular muscles. In: Buttner-Ennever J, editor. Neuroanatomy of the oculomotor system. Amsterdam: Elsevier, 1988; 33–79.
- Porter JD, Baker RS. Muscles of a different 'color': the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease. Neurology. 1996;46:30–37.
- Porter JD, Khanna S, Kaminski HJ, Merriam AP, Richmonds CR, Leahy P, Andrade FH. Extraocular muscle is defined by a fundamentally distinct gene expression profile. Proc Natl Acad Sci USA. 2001; 98:12062–12067.
- Han Y, Wang J, Fischman DA, Biller HF, Sanders I. Slow tonic muscle fibers in the thyroarytenoid muscles of human vocal folds; a possible specialization for speech. Anat Rec. I999;256(2):I46–157.
- Jacoby J, Chiarandini DJ, Stefani E. Electrical properties and innervation of fibers in the orbital layer of rat extraocular muscles. J Neurophysiol. 1989;61:116–125.
- Kaminski H. Acetylcholine receptor epitopes in ocular myasthenia. Ann NY Acad Sci. 1998;841:309–320.
- Kaminski H, Kernich C, Kusner L. Ocular myasthenia. Adv Clin Neurosci. 1996;6:37–54.
- Leigh RJ, Zee DS. The neurology of eye movements. 3rd ed. Philadelphia: F.A. Davis, 1999.
- Fuchs A, Scudder C, Kaneko C. Discharge patterns and recruitment order of identified motoneurons and internuclear neurons in monkey abducens nucleus. J Neurophysiol. 1988;60:1874–1895.
- Fuchs A, Becker W, Ling L, Langer T, Kaneko C. Discharge patterns of levator palpebrae superi-oris motoneurons during vertical lid and eye movements in the monkey. J Neurophysiol. 1992;68:233–243.
- Goldberg SJ, Meredith MA, Shall MS. Extraocular motor unit and whole-muscle responses in the lateral rectus muscle of the squirrel monkey. J Neurosci. 1998;18(24): 10629–10639.
- Fuchs AF, Binder MD. Fatigue resistence of human extraocular muscles. J Neurophysiol. 1983;49:28–34.
- Kim Y, Zahm D, Liu H, Johns T. Safety margin of neuromuscular transmission in rat extraocular muscle (Abstract). Soc Neurosci. 1982;8:616.
- Mosier DR, Siklós L, Appel S. Resistance of extraocular motoneuron terminals to effects amyotropic lateral sclerosis sera. Neurology. 2000;54:252–255.
- Ruff RL, Kaminski HJ, Maas E, Spiegel R Ocular muscles: physiology and structure-function correlations. Bull Soc Belg Ophtalmol. 1989;237:321–352.
- Lennon V. Serologic profile of myasthenia gravis and distinction from Lambert-Eaton myasthenic syndrome. Neurology. 1997;48 (Suppl. 5):S23–27.
- Barton JJ, Jama A, Sharpe JA. Saccadic duration and intrasaccadic fatigue in myasthenic and nonmyasthenic ocular palsies. Neurology. 1995;45(1 I):2065–2072.
- Barton J, Huaman A, Sharpe J. Effects of edrophonium on saccadic velocity in normal subjects and nonmyasthenic ocular palsies. Ann Neurol. 1994;36:585–594.
- Oda K, Shibasaki H. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle. Brain Res. 1988;449:337–340.
- Vincent A, Newsom-Davis J. Anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry.1980;43:590–600.
- Tindall R. Humoral immunity in myasthenia gravis: biochemical characterization, acquired antireceptor antibodies, and clinical correlations. Ann Neurol. 1981;10:437-44.7 .
- Hayashi M, Kida K, Yamada I, Matsuda H, Tsuneishi M, Tamura 0. Differences between ocular and generalized myasthenia gravis: binding characteristics of anti-acetylcholine receptor antibody against bovine muscles. J Neuroimmunol. 1989;21: 227–233.
- MacLennan C, Beeson D, Buijs A-M, Vincent A, Newsom-Davis J. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol. 1997;41:423–431.
- Wang Z, Diethelm-Okita B, Okita D, Kaminski H, Howard J, Conti-Fine B. T-cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis. J Neuroimmunol. 2000;108:29–39.
- Kaminski H, Ruff R. Ocular muscle involvement by myasthenia gravis. Ann Neurol. 1997;41:419–420.
- Kaminski HJ, Santillan C, Wolfe GI. Autoantibody testing in neuromuscular disorders. Neuromuscular junction and muscle disorders. J Clin Neuromusc Dis. 2000;2:96–105.
- Oda K, Ito Y. Myasthenia gravis: antibodies to acetylcholine receptor in ocular myasthenia gravis. J Neurol. 1981;225:251–258.
- Limburg PC, The TC, Hummel-Teppel E, Oosterhuis H. Anti-acetylcholine receptor antibodies in myasthenia gravis. I. Relation to clinical parameters in 250 patients. J Neurol Sci. 1983;58: 357–370.
- Porter JD, Burns LA, May PJ. Morphological substrate for eyelid movements: innervation and structure of primate levator palpebrae superioris and obicularis oculi muscles. J Comp Neurol. 1989; 287:64–81.
- Porter JD, Strebeck S, Capra NE Botulinum-induced changes seen in monkey eyelid muscle. Comparison with changes seen in extraocular muscle. Arch Ophthalmol. 1991;109: 396–404.
- O'Neill JH, Murray NMF, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain. 1988;111:577–596.